Antti Saraste profile picture
Antti
Saraste
Professor, Internal Medicine
MD, PhD, FESC

Contact

Areas of expertise

Cardiology
Imaging
Diagnostics
Coronary artery disease
Heart failure, Valvular heart disease

Biography

Medical Doctor 2000, Univeristy of Turku; PhD 2000 University of Turku; Associate Professor (tenure track) 2012, University of Turku; Professor 2020, University of Turku; Specialist in Cardiology 2007, University of Turku

Teaching

Cardiology, Cardiac imaging

Research

Multi modality imaging of cardiovascular diseases

Publications

Sort by:

Comparing Folate Receptor β Targeting Tracers in Experimental Myocarditis Model (2022)

Annual Congress of European Association of Nuclear Medicine and Molecular Imaging, European Journal of Nuclear Medicine and Molecular Imaging
Atencio Herre E, Li X, Liljenbäck H, Andriana P, Jahandideh A, Iqbal I, Dillemuth P, Kärnä S, Virta J, Mansour H, Cleveland NA, Low PS, Knuuti J, Saraste A, Roivainen A
(Vertaisarvioimaton konferenssijulkaisu (B3))

Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study (2022)

European Journal of Heart Failure
Venkateshvaran A, Faxen UL, Hage C, Michaelsson E, Svedlund S, Saraste A, Beussink-Nelson L, Fermer ML, Gan LM, Tromp J, Lam CSP, Shah SJ, Lund LH
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) (2022)

European Heart Journal
Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristic A, Sade LE, Schirmer H, Schupke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van der Meer P, Wojakowski W, Zacharowski K, Knuuti J, Kristensen SD, Aboyans V, Ahrens I, Antoniou S, Asteggiano R, Atar D, Baumbach A, Baumgartner H, Bohm M, Borger MA, Bueno H, Celutkiene J, Chieffo A, Cikes M, Darius H, Delgado V, Devereaux PJ, Duncker D, Falk V, Fauchier L, Habib G, Hasdai D, Huber K, Iung B, Jaarsma T, Konradi A, Koskinas KC, Kotecha D, Landmesser U, Lewis BS, Linhart A, Lochen ML, Maeng M, Manzo-Silberman S, Mindham R, Neubeck L, Nielsen JC, Petersen SE, Prescott E, Rakisheva A, Saraste A, Sibbing D, Siller-Matula J, Sitges M, Stankovic I, Storey RF, Ten Berg J, Thielmann M, Touyz RM
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest-a substudy of the XeHypotheca trial (2022)

Neuroradiology
Koskensalo K, Virtanen S, Saunavaara J, Parkkola R, Laitio R, Arola O, Hynninen M, Silvasti P, Nukarinen E, Martola J, Silvennoinen HM, Tiainen M, Roine RO, Scheinin H, Saraste A, Maze M, Vahlberg T, Laitio TT; XeHYPOTHECA Research Group
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))